The European AI in antibody generation market is undergoing a significant surge, driven primarily by increasing investments in biotechnology and a stronger focus on personalized medicine. Experts predict remarkable advancements in therapeutic antibody development utilizing artificial intelligence, particularly within areas like oncology and immunot